| BTK inhibitors vary in potency, selectivity, and tissue distribution. |
| Tolebrutinib had the most favorable combination of potency and CSF exposure for meaningful CNS target engagement. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.